Science 37 Holdings, Inc.
SNCE · NASDAQ
12/31/2022 | 12/31/2021 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | -0.00 | -0.00 | 0.00 |
| FCF Yield | -11.15% | -700.04% | -1.06% | 0.00% |
| EV / EBITDA | -6.14 | 8.33 | -111.21 | 0.00 |
| Quality | ||||
| ROIC | -101.22% | -28.22% | -79.06% | 0.00% |
| Gross Margin | 22.62% | 28.87% | 4.67% | 0.00% |
| Cash Conversion Ratio | 1.48 | 0.39 | 0.80 | – |
| Growth | ||||
| Revenue 3-Year CAGR | 43.57% | – | 2,872,491.56% | -100.00% |
| Free Cash Flow Growth | -88.10% | -80.31% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.77 | 8.66 | 1.13 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 9.87 | 0.00 |
| Cash Conversion Cycle | 8.74 | -44.84 | 207.30 | 0.00 |